Yogendra Singh

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Peripheral Blood

Top Venues

Drug development research

British journal of clinical pharmacology

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Yogendra Singh, Neeraj Kumar Fuloria, Shivkanya Fuloria, Vetriselvan Subramaniyan, Waleed Hassan Almalki, Fahad A Al-Abbasi, Imran Kazmi, Sobhit Singh Rajput, Nirmal Joshi, Gaurav Gupta
A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV-2 mediated inflammation to organ damage. British journal of clinical pharmacology 88 (8) (2022)
Yogendra Singh, Neeraj Kumar Fuloria, Shivkanya Fuloria, Vetriselvan Subramaniyan, Dhanalekshmi Unnikrishnan Meenakshi, Srikumar Chakravarthi, Usha Kumari, Navneet Joshi, Dinesh Kumar Chellappan
N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals. Journal of medical virology 93 (10) (2021)
Yogendra Singh, Neeraj Kumar Fuloria, Shivkanya Fuloria, Vetriselvan Subramaniyan, Waleed Hassan Almalki, Gaurav Gupta, Mohammad Arshad Javed Shaikh, Mahaveer Singh, Fahad A Al-Abbasi, Imran Kazmi
Disruption of the biological activity of protease-activated receptors2/4 in adults rather than children in SARS CoV-2 virus-mediated mortality in COVID-19 infection. Drug development research 82 (8) (2021)
Mousmee Sharma, Parteek Prasher, Meenu Mehta, Flavia C Zacconi, Yogendra Singh, Deepak N Kapoor, Harish Dureja, Dinesh M Pardhi, Murtaza M Tambuwala, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug development research (2020)